MedPath

Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx Paraganglioma

Conditions
Genetic Predisposition
Environmental Exposure
SDH Gene Mutation
Registration Number
NCT04481152
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers

Detailed Description

The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers.

Patients will be selected from subjects with a mutation in one of the SDHx genes. The cases will have developed a tumor, while the controls will be tumor-free. Controls will be matched to the cases according to sex, age and type of gene affected. Past exposures will be sought through a telephone questionnaire.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Cases: SDHx mutation carriers diagnosed for a SDHx-related tumor
  2. Controls: SDHx mutation carriers with no SDHx-related tumor
Exclusion Criteria

Incapacity to exercise free and informed consent for the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasability of the protocol of a national case/control study (PGL.EXPO2)2 years

Successful pairing of 50 cases with 50 controls

Secondary Outcome Measures
NameTimeMethod
Ease of matching cases and controls2 years

Mean number of controls matching for a case

Feasibility of matching cases and controls2 years

Proportion of cases for which a control could be identified

© Copyright 2025. All Rights Reserved by MedPath